Study Evaluating Subjects With Distal Renal Tubular Acidosis
Status:
Not yet recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
This is a phase 3, prospective, multicenter, randomized, double-blinded, placebo-controlled,
study product withdrawal study comparing the efficacy of ADV7103 versus placebo in preventing
the development of metabolic acidosis defined by serum bicarbonate level in pediatric (6
months to < 18 years of age) and adult (18 to 65 years of age) subjects with primary dRTA.